Home › Funds › Cambridge Financial Group, Inc. › ABBV

Cambridge Financial Group, Inc. position in ABBV

ABBVIE INC · Health Care

Cambridge Financial Group, Inc. reported holding 36,795 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$9.6M, representing 3.53% of its reported portfolio and ranking #12 among its reported holdings. Cambridge Financial Group, Inc. has disclosed ABBV holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)36.80K sh
Reported value held$9.63M
Portfolio Weight3.53%
First reportedQ3 2023
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Cambridge Financial Group, Inc.'s ABBV position evolved

Cambridge Financial Group, Inc. first disclosed a stake in ABBV in Q3 2023 at 34,320 shares (US$5.1M). The position peaked in Q3 2026 at 36,795 shares, worth US$9.6M. Across 11 filings, Cambridge Financial Group, Inc. increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 36,795 shares valued at US$9.6M — a reduction of -1,231 shares quarter over quarter.. Notable position changes include a 28% trim in Q2 2025 (shares rose 26% over the following quarter), a 38% increase in Q3 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 34.32K $5.12M New
Q4 2023 31.69K $4.91M Reduce
Q1 2024 33.73K $6.14M Add
Q4 2024 38.30K $6.81M Add
Q1 2025 38.00K $7.96M Reduce
Q2 2025 27.30K $5.07M Reduce
Q3 2025 37.73K $8.74M Add
Q4 2025 36.81K $8.41M Reduce
Q1 2026 37.17K $8.08M Add
Q2 2026 38.03K $9.57M Add
Q3 2026 36.80K $9.63M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 34 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Cambridge Financial Group, Inc. held ABBV?

Cambridge Financial Group, Inc. has disclosed ABBV holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

What is Cambridge Financial Group, Inc.'s current position in ABBV?

As of Q3 2026, Cambridge Financial Group, Inc. holds 36.80K shares of ABBV (ABBVIE INC), valued at $9.63M, representing 3.53% of its reported portfolio and ranking #12.

Has Cambridge Financial Group, Inc. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Cambridge Financial Group, Inc. reduced its position in ABBV. The position peaked in Q3 2026 at 36.80K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.